Ekso Bionics (EKSO) Holdings entered into an agreement with Israel-based MediTouch to become the exclusive authorized sales agent and distributor of MediTouch’s BalanceTutor rehabilitation system in the United States.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on EKSO:
- China Flags Humanoid Robot Bubble Risk as Investor Hype Grows
- Ekso Bionics’ Strong Q3 2025 Recovery and Strategic Prospects Lead to Buy Rating
- Ekso Bionics price target raised to $6 from $4 at H.C. Wainwright
- Ekso Bionics Announces Executive Equity Award Grants
- Ekso Bionics Announces $3.2 Million Stock Offering